ReproCELL Incorporated (TYO:4978)

Japan flag Japan · Delayed Price · Currency is JPY
212.00
+5.00 (2.42%)
Aug 1, 2025, 3:30 PM JST
2.42%
Market Cap20.07B
Revenue (ttm)2.98B
Net Income (ttm)103.00M
Shares Out94.69M
EPS (ttm)1.11
PE Ratio191.11
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,199,400
Average Volume2,661,925
Open209.00
Previous Close207.00
Day's Range206.00 - 215.00
52-Week Range97.00 - 277.00
Beta0.78
RSI55.54
Earnings DateAug 13, 2025

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 99
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4978
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.